TherapeuticsMD (TXMD) Gross Profit (QoQ) (2011 - 2023)
Powered by 
Analysis
TherapeuticsMD (TXMD) Gross Profit (QoQ) (2011 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 1,047.17% |
| Sep 30, 2023 | -112.13% |
| Jun 30, 2023 | 5.05% |
| Mar 31, 2023 | -99.39% |
| Mar 31, 2022 | 3.82% |
| Dec 31, 2021 | -30.72% |
| Sep 30, 2021 | 6.65% |
| Jun 30, 2021 | 24.31% |
| Mar 31, 2021 | -10.70% |
| Dec 31, 2020 | 5.81% |
| Sep 30, 2020 | 154.93% |
| Jun 30, 2020 | -33.92% |
| Mar 31, 2020 | -26.78% |
| Dec 31, 2019 | -41.54% |
| Sep 30, 2019 | 361.18% |
| Jun 30, 2019 | 51.70% |
| Mar 31, 2019 | -23.07% |
| Dec 31, 2018 | 49.15% |
| Sep 30, 2018 | -16.14% |
| Jun 30, 2018 | 5.42% |